GlaxoSmithKline and Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics. Verily Life Sciences–known as Google’s life sciences unit until last year–and Britain’s biggest drug maker will together contribute 540 million pounds ($715.12 million) over…

http://fortune.com/2016/08/01/google-alphabet-glaxosmithkline-bioelectronics/

Advertisements